Article
Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
Cancer research - 15 Oct 2004
Rios-Doria Jonathan, Kuefer Rainer, Ethier Stephen P, Day Mark L
Abstract excerpt
Mutations in the NH(2)-terminal regulatory domain of the beta-catenin gene lead to aberrant stabilization and accumulation of the protein and increased TCF/LEF-dependent transcription. Although these mutations are common in some cancers, they are infrequent in prostate and breast cancer. We have found that metastatic prostate cancer specimens, obtained through a rapid autopsy tissue procurement program, expressed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
